Phase 4
Completed N=17
The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown
Skin Infection
Source: ClinicalTrials.gov NCT03929224 ↗
Enrolled (actual)
17
Serious AEs
0.0%
Results posted
Aug 2022
Primary outcomePrimary: Holgers Classification of Skin Reactions at the Surgical Site Graded 0 (no Reaction) to 4 (Worse Outcome) — 1.06; 0.64; 0.81; 0.50 Grade
◆ Published Evidence
No publication linked
No peer-reviewed publication reporting this trial's results has been linked yet. This can indicate results are unpublished — a known publication-bias signal. We re-check periodically.
Summary
Postoperative medicinal grade honey in post-operative care may prevent bone anchored hearing aid associated skin breakdown better than standard care of bacitracin ointment alone in adult patients.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Holgers Classification of Skin Reactions at the Surgical Site Graded 0 (no Reaction) to 4 (Worse Outcome) |
1.06; 0.64; 0.81; 0.50; 1.25; 0.68 | — |
| SECONDARY Number of Participants Requiring Oral Antibiotics |
4; 0 | — |
| SECONDARY Assessment of Pain at the Abutment Site Using the 0-10 Pain Scale With 0 Being no Pain At All and 10 Being the Worst Possible Pain |
5.00; 2.00; 7.33; 3.00; 5.83; 0.58 | — |
Eligibility Criteria
Inclusion Criteria
- patients undergoing bone-anchored hearing aid implantation surgery.
Exclusion Criteria
- patients who are undergoing revision bone-anchored hearing surgery, history of radiation to the implantation site.
Data sourced from ClinicalTrials.gov (NCT03929224). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.